STAT+: Inside Moderna and Merck’s cancer vaccine triumph

Nobody's calling it a gambit now that it worked. Success has excellent PR.

Moderna and Merck's wild gambit on a cancer vaccine appears to have worked, despite big doubts, logistical challenges, and pandemic-era complications.